Dr Hector Izurieta | Epidemiologist, Immediate Office of the Director. Office of Biostatistics and Epidemiology, CBER
U.S. Federal Drug Administration | United States

Dr Hector Izurieta, Epidemiologist,  Immediate Office of the Director. Office of Biostatistics and Epidemiology, CBER, U.S. Federal Drug Administration

Hector Izurieta, M.D., M.P.H., has an MPH from Harvard, a Preventive Medicine (Fellowship) degree from CDC, a two-year training in epidemiology at the CDC’s Epidemic Intelligence Service (EIS), in Atlanta, Georgia. He has extensive experience collaborating in multicenter (and multinational), large observational studies with CDC, the Food and Drug administration (FDA), the Centers for Medicare and Medicaid Services (CMS), the World Health Organization (WHO), and other leading U.S. and international organizations. His current appointment is as senior epidemiologist under the Associate Director for Research, in the Immediate Office of the Director, Office of Biostatistics and Epidemiology, performing innovative observational studies on vaccine and biologics effectiveness and safety.

Appearances:



DC Co-conference Day 2 April 4 @ 11:40

Panel: Improving active vaccine & immunotherapy safety surveillance in resource-limited settings

  • The use of self-control approaches for investigation of vaccine adverse events
    • Examples
  • The need for pharmacoepidemiologic studies to evaluate immune-mediated reaction (IMR) signals in response to checkpoint inhibitor treatment

back to speakers